Is the medtech industry healthy? A report titled, Pulse of the Industry Medical Technology Report 2022, shows that the industry is healthy – but faces a host of new and emerging challenges.
One of the biggest factors in the study is the reduced appetite for M&A from the medtech industry. The report points out there has been a 13% drop in the number of deals signed in the 12-months ending June 30, 2022 – despite M&A spending being up 24%.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,